MISSOURI: State Legislation Aims to Curb Spread of STDs CDC Daily UpdateImportant note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow




MISSOURI: State Legislation Aims to Curb Spread of STDs

St. Louis Post-Dispatch (12.21.07) - Thursday, December 20, 2007
Blythe Bernhard


Under newly introduced legislation, some Missouri health care providers who diagnose chlamydia or gonorrhea in a patient would be allowed to prescribe treatment for the patient's partner without examining him or her.

CDC reports that at least 11 other states have already approved bills permitting expedited partner therapy. The Missouri law, however, would only apply to cities or counties where rates of the diseases significantly exceed the US average. St. Louis leads the nation in rates of both diseases.

"[Patients] are continuously transmitting this disease back and forth, and if they're treated, it will help wipe this out and keep our numbers down," said Rep. Juanita Head Walton (D- North St. Louis County), the measure's sponsor.

A 2006 CDC report identified some problems with the approach. It said unexamined patients may have other health issues that need treatment, and they might be allergic to antibiotics. Also, patients who do not present in person cannot be counseled about preventing future infections. Even so, CDC found the technique useful.

"We really have an extraordinary situation, and we think this is one more tool that would help us address it," said Michael P. Williams, the St. Louis County Department of Health's director of communicable disease control. He said the department is anxious to begin expedited partner therapy if the bill becomes law.
071220
AD072652


Copyright © 2007 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.